Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257.HK) issued an announcement. All prerequisites of the subscription agreement have been met, and the subscription matters were completed on August 12, 2026. A total of 2,435,600 subscribed shares (accounting for approximately 2.17% of the number of shares issued immediately after completion) have been allocated and issued to the subscribers at the subscription price of HK$4.69 per subscription share in accordance with the terms and conditions of the subscription agreement. The net proceeds from the subscription process were approximately HK$11.3 million. The Group intends to use the proceeds from the subscription process as its general working capital.

Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257.HK) issued an announcement. All prerequisites of the subscription agreement have been met, and the subscription matters were completed on August 12, 2026. A total of 2,435,600 subscribed shares (accounting for approximately 2.17% of the number of shares issued immediately after completion) have been allocated and issued to the subscribers at the subscription price of HK$4.69 per subscription share in accordance with the terms and conditions of the subscription agreement. The net proceeds from the subscription process were approximately HK$11.3 million. The Group intends to use the proceeds from the subscription process as its general working capital.